Fig. 2From: Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancerReceiver operating characteristic curves of hsa-miR-21 (a), hsa-miR-221 (c), hsa-miR-135b (e) and hsa-miR-29c (g) differentiating OSCC patients from normal controls and those differentiating between normal controls and adjacent tissue using hsa-miR-21 (b), hsa-miR-221 (d), hsa-miR-135b (f) and hsa-miR-29c (h)Back to article page